Results 121 to 130 of about 31,601 (273)

A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)

, 2022
Sanjiv S. Agarwala, Ulrich O. Nagl, Xinghua Guo, Anne Bellon, Jens Heyn, Miryana Dimova-Dobreva, Yuming Shen, Gregor Schaffar, M.F. Humphrey, Nicola Mathieson, Natalia Koptelova, Sreekanth Gattu   +11 more
openalex   +1 more source

Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives

Advanced Materials, Volume 38, Issue 4, 16 January 2026.
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin, Liliang Ouyang, Khoon S. Lim, Antonella Motta, Devid Maniglio, Lorenzo Moroni, Carlos Mota   +6 more
wiley   +1 more source

The impact of financial incentives promoting biosimilar products in oncology: A quasi-experimental study using administrative data.

PLoS ONE
BackgroundBiosimilars have the potential to save a significant amount of money in cancer treatment costs. However, barriers exist in the adoption of biosimilar products.
Hisashi Itoshima, Daisuke Takada, Etsu Goto, Noriko Sasaki, Susumu Kunisawa, Yuichi Imanaka   +5 more
doaj   +1 more source

Biosimilars: Approval and Acceptance? [PDF]

, 2011
Jessica K. DeMartino
openalex   +1 more source

Therapeutic drug monitoring education: The current state

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 198-209, January 2026.
Aims To evaluate available information on therapeutic drug monitoring (TDM) education programmes and their implementation across different countries. Methods The study was performed in two phases. First, a scoping review of scientific literature on available education programmes was performed.
Guenka Petrova, Stiliyana Blagova, Konstantin Tachkov, Marlene Santos, James Bluett, Merita Rumano, Elena Kkolou, Elena Drakalska, Marija Arev, Mehtap Cakmak Barsbay, Denis Mulleman   +10 more
wiley   +1 more source

Reviews Brand-name drug, generic drug, orphan drug. Pharmacological therapy with biosimilar drugs – provision of due diligence in the treatment process [PDF]

, 2013
Justyna Zajdel, Radosław Zajdel
openalex   +1 more source

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review

ClinicoEconomics and Outcomes Research
Grace E Fox,1 Mark Bernauer,1 Jennifer M Stephens,1 Bianca Jackson,1 Joshua A Roth,2 Ahmed Shelbaya2,3 1Strategic Market Access, OPEN Health, Bethesda, MD, USA; 2Global Access and Value, Pfizer Inc., New York, NY, USA; 3Department of Epidemiology ...
Fox GE, Bernauer M, Stephens JM, Jackson B, Roth JA, Shelbaya A   +5 more
doaj  

Uptake of biosimilars in China: a retrospective analysis of the case of trastuzumab from 2018 to 2023

Global Health Research and Policy
Background The Chinese biosimilar industry has demonstrated rapid growth in recent years. Limited evidence is available about biosimilar uptake at the national level.
Qiyou Wu, Zhitao Wang, Yihan Fu, Ren Luo, Jing Sun   +4 more
doaj   +1 more source

G-CSF and G-CSF biosimilars: a meta-analysis of randomized clinical trials in breast cancer patients [PDF]

, 2017
Edoardo Botteri, Andriy Krendyukov, Giuseppe Curigliano   +2 more
openalex   +1 more source

Upconverting Nanoparticle‐Loaded Microneedles for Near‐Infrared Responsive Delivery of Gonadotropins to Increase Success of In Vitro Fertilization

Small, Volume 22, Issue 1, 2 January 2026.
This paper describes the development of an upconverting particle‐integrated microneedle patch that can release the hormone leuprolide when the patch is exposed to near‐infrared light. This system represents proof‐of‐concept of a painless and automated method of delivering drugs at specific times when repeated time‐sensitive injections are required ...
Vivienne Tam, Rusvir Trana, Alfonso Nieto‐Arguello, Ore‐Oluwa Olasubulumi, Samuel Babity, Artiom Skripka, Fiorenzo Vetrone, Davide Brambilla, Marta Cerruti   +8 more
wiley   +1 more source